GENEVOLVE is the new Genomic division of Dr Lal PathLabs with a focused foray into Genetic testing. With the advent of this division, Dr Lal PathLabs you can now expect many revolutionary and path-breaking novel tests leveraging the latest technologies resulting in faster TAT & quality reports at the most affordable prices! GENEVOLVE offers a wide range of key tests related to Oncogenomics, Neurogenomics, Rare disease & Pre-natal/Post-natal genetic testing using cutting edge technologies such as Next Generation Sequencing (NGS), MLPA, ddPCR, FISH & Sanger Sequencing, etc. All these tests are performed at our National Reference Lab located at Rohini, New Delhi. With an experience of over 7 decades, the infrastructure of 190 clinical laboratories, 2100 collection centers, and 5500 pick- up points spread across the country, we proudly wish to be your preferred choice for most reliable genetic testing service provider. GENEVOLVE brings the dawn of a new era of Genomic testing!
| Website | http://www.lalpathlabs.com |
| Revenue | $274.6 million |
| Employees | 7 (4 on RocketReach) |
| Industry | Biotechnology Research |
| Keywords | Health Diagnostics, Genetic Testing, Genome Sequencing Services, Genomic Testing, Dna Testing, Clinical Genomics, Molecular Diagnostics, Genetic Screening, Genome Sequencing, Personalized Medicine, Precision Medicine, Diagnostic Testing, Healthcare Diagnostics, Medical Diagnostics, Genetic Analysis, Genomic Analysis, Dna Sequencing, Clinical Laboratory, Pathology Lab, Medical Laboratory |
| Competitors | Mayo Clinic Laboratories, Quest Diagnostics, Labcorp, Eurofins, Exact Sciences, BioReference Laboratories, ARUP Laboratories, Invitae, PathGroup, Sonic Healthcare +37 more (view full list) |
Looking for a particular Genevolve employee's phone or email?
The Genevolve annual revenue was $274.6 million in 2026.
4 people are employed at Genevolve.